Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Edgewise Therapeutics, Inc. (EWTX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 28 Jun 2022, 19:16.
Jonathan D. Root - 24 Jun 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)
- Role
- Director
- Signature
- /s/ John R. Moore Attorney-in-Fact for Jonathan Root M.D.
- Issuer symbol
- EWTX
- Transactions as of
- 24 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 28 Jun 2022, 19:16:58 UTC
- Previous filing
- 13 Jun 2022
- Next filing
- 19 May 2023
- SEC
- View on sec.gov
Key filing fact
Jonathan D. Root filed Form 4 for Edgewise Therapeutics, Inc. (EWTX) on 28 Jun 2022.
Change
- Previous filing in this sequence was filed on 13 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
EWTX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +42,087
- Change %
- Price
- $0.000000
- Shares after
- 42,087
- Date
- 24 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 42,087
- Exercise price
- $8.53
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 100% of the Stock Options granted on June 24, 2022 will become vested on the earlier of (i) June 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders. |